Officials with the American Cancer Society, which is the biggest private, not-for-profit funder of cancer research, recently announced that they intend to double the organization’s yearly research funding by the year 2021.
The Partnership for Research on Ebola Virus in Liberia (PREVAIL) IV treatment trial recently launched in Liberia, testing a treatment for men who survived Ebola but still have the genetic material (RNA) of the virus in their semen.
Leaders with the American Cancer Society Cancer Action Network (ACS CAN) recently started a new ad campaign that encourages the public and Congress to focus on prioritizing federal funding dedicated to cancer research.
Leaders with the U.S. Preventive Services Task Force (USPSTF) recently released a final recommendation statement as well as evidence summary to encourage adults between 50 and 75 years old to receive colorectal cancer screening.
Merck KGaA in Darmstadt, Germany, recently welcomed Hamilton Thorne and ZEISS as the two most recent members of the company’s Global Fertility Alliance, which already includes Illumina, Genea and Merck KGaA.
Leaders at the American Cancer Society (ACS) as well as the American Cancer Society Cancer Action Network (ACS CAN) recently announced that the agencies will increase their research funding by two times.
A recent federal analysis from the National Institutes of Health (NIH) shows that Americans have spent $30.2 billion out-of-pocket for complementary health methods, including meditation, herbal supplements, yoga and chiropractic services.
Takeda Pharmaceutical Company Limited recently announced that it has received a significant grant from the Bill & Melinda Gates Foundation to support Takeda’s ongoing polio eradication efforts, which are taking place in developing countries.
Leaders with the National Institutes of Health (NIH) and Fundacao Oswaldo Cruz-Fiocruz, a scientific research organization connected to the Brazilian Ministry of Health, recently enrolled approximately 10,000 women in a study about the Zika virus and pregnancy.
Leaders in the worldwide HAE community recently gathered at the 2016 CSL Behring event on May 16 to recognize the fifth annual HAE Day initiative from HAEi, a worldwide patient organization dedicated to C1-inhibitor deficiency.